CoChat

Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities

Open access
Fujita, Wakako, Gomes, Ivone, Devi, Lakshmi A · 2015 · British Journal of Pharmacology
Cited by 98

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Several studies suggest that heteromerization between μ (MOP) and δ (DOP) opioid receptors modulates the signalling properties of the individual receptors. For example, whereas activation of MOP receptors by an agonist induces G protein‐mediated signalling, the same agonist induces β‐arrestin‐mediated signalling in the context of the MOP‐D OP receptor heteromer. Moreover, heteromer‐mediated signalling is allosterically modulated by a combination of MOP and DOP receptor ligands. This has implications in analgesia given that morphine‐induced antinociception can be potentiated by DOP receptor ligands. Recently reagents selectively targeting the MOP‐D OP receptor heteromer such as bivalent ligands, antibodies or membrane permeable peptides have been generated; these reagents are enabling studies to elucidate the contribution of endogenously expressed heteromers to analgesia as well as to the development of side‐effects associated with chronic opioid use. Recent advances in drug screening technology have led to the identification of a MOP‐D OP receptor heteromer‐biased agonist that activates both G protein‐mediated and β‐arrestin‐mediated signalling. Moreover, this heteromer‐biased agonist exhibits potent antinociceptive activity but with reduced side‐effects, suggesting that ligands targeting the MOP‐D OP receptor heteromer form a basis for the development of novel therapeutics for the treatment of pain. In this review, we summarize findings regarding the biological and functional characteristics of the MOP‐D OP receptor heteromer and the in vitro and in vivo properties of heteromer‐selective ligands. Linked Articles: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12663

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Fujita, W., Gomes, I., & Devi, L. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-07
Volume
172
Issue
2
Pages
375-387
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1914290984
Cited by
98
References
6
FWCI
3.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.